Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Mediclin AG (MED.DE)
EUR4.20
+0.10 (+2.44%)
DE XETRA Healthcare Medical - Care Facilities
Address
Okenstrasse 27 77652
Offenburg, DE
Offenburg, DE
CEO
Tino Fritz
Website
mediclin.de
IPO
2000-12-06
ISIN DE0006595101
Description
Mediclin AG is a German healthcare enterprise primarily engaged in managing hospitals across the nation. Its operations are categorized into three main segments: Post-Acute, Acute, and various other related activities. The company offers a comprehensive range of medical specializations, encompassing fields such as neurology, psychosomatics, orthopaedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, and surgical interventions, in addition to general nursing care. Furthermore, Mediclin provides specialized services like ear, nose, and throat (ENT) treatment and acute outpatient care. As of December 31, 2021, its extensive network comprised 34 clinics, 7 nursing care facilities, and 11 medical care centres. This infrastructure collectively provided a significant capacity of 7,831 beds and 482 nursing places, distributed across eleven of Germany's federal states. The company's corporate headquarters are situated in Offenburg, Germany.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
EUR4.20
+0.10 (+2.44%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
9.6K
Beta
0.42
Float Shares
5.83M
Free Float %
12.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.56% | +0.00% | +6.55% | -3.76% | +5.29% | -0.56% | +21.77% | +16.99% | -17.13% | -33.21% | -67.60% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
4.20
DCF (Unlevered)
119.81
+2,752.7%
DCF (Levered)
131.95
+3,041.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.52
Distress
Piotroski F-Score
7 / 9
Strong
MOAT Score
5 / 10
Developing
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+4.8% Q1'26: +1.1% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+3.9% Q1'26: +2,158.8% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+2.0% ★ Q1'26: +1.9% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+4.9% Q1'26: +5.1% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+5.0% Q1'26: +6.1% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: +6.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×3.96× Q1'26: 4.09× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
493.56M
est: 500.09M (-1.3%)
|
509.74M
est: 520.59M (-2.1%)
|
514.95M
est: 532.87M (-3.4%)
|
538.04M
est: 539.37M (-0.2%)
|
555.35M
est: 562.75M (-1.3%)
|
580.34M
est: 580.34M (+0.0%)
|
609.10M
est: 606.34M (+0.5%)
|
645.10M
est: 649.00M (-0.6%)
|
673.10M
est: 670.90M (+0.3%)
|
659.90M
est: 666.00M (-0.9%)
|
673.10M
est: 660.00M (+2.0%)
|
704.70M
est: 705.00M (0.0%)
|
730.10M
est: 730.10M (+0.0%)
|
748.80M
est: 739.44M (+1.3%)
|
784.49M
est: 776.72M (+1.0%)
|
805.60M
805.60M – 805.60M
+3.7% YoY
|
825.83M
825.83M – 825.83M
+2.5% YoY
|
846.59M
846.59M – 846.59M
+2.5% YoY
|
900.10M
900.10M – 900.10M
+6.3% YoY
|
927.10M
927.10M – 927.10M
+3.0% YoY
|
| EBITDA |
29.75M
est: 20.40M (+45.8%)
|
21.77M
est: 66.80M (-67.4%)
|
19.71M
est: 68.37M (-71.2%)
|
34.07M
est: 69.21M (-50.8%)
|
42.12M
est: 29.10M (+44.7%)
|
43.31M
est: 36.38M (+19.0%)
|
27.21M
est: 79.36M (-65.7%)
|
37.62M
est: 22.70M (+65.8%)
|
93.72M
est: 33.20M (+182.3%)
|
76.84M
est: 71.40M (+7.6%)
|
85.43M
est: 77.65M (+10.0%)
|
91.80M
est: 80.56M (+14.0%)
|
101.27M
est: 85.91M (+17.9%)
|
106.41M
est: 96.55M (+10.2%)
|
98.66M
est: 101.42M (-2.7%)
|
105.19M
105.19M – 105.19M
+3.7% YoY
|
107.83M
107.83M – 107.83M
+2.5% YoY
|
110.54M
110.54M – 110.54M
+2.5% YoY
|
117.53M
117.53M – 117.53M
+6.3% YoY
|
121.06M
121.06M – 121.06M
+3.0% YoY
|
| EBIT |
13.01M
est: 17.16M (-24.2%)
|
4.45M
est: 14.44M (-69.2%)
|
2.26M
est: 14.78M (-84.7%)
|
15.55M
est: 2.13M (+631.5%)
|
23.70M
est: 16.24M (+45.9%)
|
23.04M
est: 24.71M (-6.8%)
|
6.82M
est: 17.16M (-60.3%)
|
15.34M
est: 7.06M (+117.2%)
|
22.55M
est: 15.69M (+43.7%)
|
-512.0K
est: 21.92M (-102.3%)
|
11.77M
est: 23.84M (-50.6%)
|
20.40M
est: 24.74M (-17.5%)
|
15.26M
est: 26.38M (-42.2%)
|
56.11M
est: 75.09M (-25.3%)
|
38.44M
est: 78.88M (-51.3%)
|
81.81M
81.81M – 81.81M
+3.7% YoY
|
83.86M
83.86M – 83.86M
+2.5% YoY
|
85.97M
85.97M – 85.97M
+2.5% YoY
|
91.41M
91.41M – 91.41M
+6.3% YoY
|
94.15M
94.15M – 94.15M
+3.0% YoY
|
| Net Income |
2.98M
est: 10.15M (-70.7%)
|
-1.40M
est: 5.79M (-124.3%)
|
-2.64M
|
8.50M
est: 7.71M (+10.2%)
|
16.54M
est: 8.87M (+86.4%)
|
16.55M
est: 17.31M (-4.4%)
|
3.91M
est: 10.21M (-61.7%)
|
7.72M
est: 4.17M (+85.0%)
|
9.66M
est: 8.04M (+20.2%)
|
-9.00M
est: 9.45M (-195.2%)
|
1.46M
est: 10.28M (-85.8%)
|
9.44M
est: 10.66M (-11.5%)
|
-10.78M
est: 11.37M (-194.8%)
|
24.84M
est: 19.55M (+27.0%)
|
25.49M
est: 31.55M (-19.2%)
|
37.09M
37.09M – 37.09M
+17.6% YoY
|
39.69M
39.69M – 39.69M
+7.0% YoY
|
43.04M
43.04M – 43.04M
+8.4% YoY
|
49.51M
49.51M – 49.51M
+15.0% YoY
|
52.98M
52.98M – 52.98M
+7.0% YoY
|
| SGA |
6.30M
est: 271.05M (-97.7%)
|
7.60M
est: 8.74M (-13.0%)
|
6.40M
est: 8.94M (-28.4%)
|
7.20M
est: 352.44M (-98.0%)
|
8.30M
est: 376.44M (-97.8%)
|
8.50M
est: 387.77M (-97.8%)
|
9.50M
est: 10.38M (-8.5%)
|
8.60M
est: 464.90M (-98.2%)
|
10.20M
est: 462.98M (-97.8%)
|
9.60M
est: 407.20M (-97.6%)
|
8.70M
est: 442.84M (-98.0%)
|
5.60M
est: 459.46M (-98.8%)
|
18.00M
est: 489.95M (-96.3%)
|
19.10M
est: 272.12M (-93.0%)
|
75.37M
est: 25.96M (+190.3%)
|
26.92M
26.92M – 26.92M
+3.7% YoY
|
27.60M
27.60M – 27.60M
+2.5% YoY
|
28.29M
28.29M – 28.29M
+2.5% YoY
|
30.08M
30.08M – 30.08M
+6.3% YoY
|
30.99M
30.99M – 30.99M
+3.0% YoY
|
| EPS |
0.06
est: 0.10 (-40.6%)
|
-0.03
est: 0.12 (-124.3%)
|
-0.06
|
0.18
est: 0.16 (+11.4%)
|
0.35
est: 0.26 (+33.3%)
|
0.35
est: 0.40 (-13.1%)
|
0.08
est: 0.22 (-62.8%)
|
0.16
est: 0.42 (-61.9%)
|
0.20
est: 0.21 (-4.8%)
|
-0.19
est: -0.15 (-25.3%)
|
0.03
est: -0.13 (+123.7%)
|
0.20
est: 0.18 (+11.1%)
|
-0.23
est: -0.23 (+0.0%)
|
0.52
est: 0.41 (+26.3%)
|
0.54
est: 0.66 (-18.7%)
|
0.78
0.78 – 0.78
+17.6% YoY
|
0.84
0.84 – 0.84
+7.0% YoY
|
0.91
0.91 – 0.91
+8.4% YoY
|
1.04
1.04 – 1.04
+15.0% YoY
|
1.12
1.12 – 1.12
+7.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-19 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-18 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-15 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-13 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-12 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-11 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-07 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-06 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-05 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-04 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-29 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
78.65M
OE per share TTM
1.64
Owner's Yield
43.58%
Maintenance CapEx ratio
1,970.82%
Maint CapEx / Avg PPE
76.2%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
5.3K
Shares Outstanding
47.50M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bärbel Merz | Head of Group Controlling | — | female |
| Carin Emminghaus | Head of Payroll & Application Management | — | female |
| Ender Gulcan | Head of Investor Relations & ESG | — | — |
| Frank Heuberger | Head of Finance & Accounting | — | male |
| Jörg Störmer | Head of Purchasing & Medical Technology | — | male |
| Katja Kiesewetter | Head of Law | — | female |
| Mario Waidele | Head of Group Accounting | — | male |
| Ralf Bürgy | Head of Quality Medicine & Head of Internal Auditing | — | — |
| Thomas Piefke | Chief Operating Officer & Member of Management Board | — | male |
| Tino Fritz | Chief Financial Officer & Member of the Management Board | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MED.DE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
